How it works
Estradiol binds estrogen receptors (ERα, ERβ) throughout the body, restoring estrogen signaling lost during perimenopause and menopause. Effects span the central nervous system, vasomotor regulation, bone remodeling, and urogenital tissue.
The evidence
The Women's Health Initiative (WHI) and subsequent re-analyses support estradiol HRT (transdermal preferred for clotting safety) initiated within 10 years of menopause onset for vasomotor and bone outcomes. Transdermal delivery avoids first-pass hepatic metabolism and has a more favorable thrombotic profile than oral estrogens.
Typical dosing
Transdermal patches: 0.025–0.1 mg/day. Oral estradiol: 0.5–2 mg/day. Always paired with progesterone (oral micronized) in patients with an intact uterus.
Side effects
Common
- Breast tenderness
- Spotting (early)
- Bloating
- Mood changes
Less common
- Headaches
- Nausea
Rare
- Venous thromboembolism (higher with oral)
- Cholestatic liver effects
Drug interactions
- CYP3A4 inducers (rifampin, St. John's Wort) — may reduce effect
- Anticoagulants — adjust monitoring
- Thyroid replacement — may need dose adjustment